Horizon Therapeutics Public Ltd Co
HZNPDelisted Oct 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492426
Horizon Therapeutics Public Ltd Co was delisted on Oct 6, 2023; its insiders filed their last Form 4 on Oct 6, 2023; 483 institutions reported holding it in 13F filings for Q3 2023, worth $24.8B in total; Soros Fund Management was the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Horizon Therapeutics Public Ltd Co insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Horizon Therapeutics Public Ltd Co, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sherman Jeffrey W | EVP and Chief Medical Officer | 0Indirect | Oct 6, 2023 | 0 |
| Grey Michael G | Director | 0Indirect | Oct 6, 2023 | 0 |
| Santini Gino | Director | 0Indirect | Oct 6, 2023 | 0 |
| Watkins Thomas | Director | 0Indirect | Oct 6, 2023 | 0 |
| Himawan Jeff | Director | 0Indirect | Oct 6, 2023 | 0 |
| Walbert Timothy P | Chairman, President and CEO | 0Indirect | Oct 6, 2023 | 0 |
| Mahony Susan | Director | 0Indirect | Oct 6, 2023 | 0 |
| Shannon James Samuel | Director | 0Indirect | Oct 6, 2023 | 0 |
| DesJardin Michael A. | EVP, Technical Operations | 0 | Oct 6, 2023 | 0 |
| Daniel William F | Director | 0Indirect | Oct 6, 2023 | 0 |
| Witz Pascale | Director | 0Indirect | Oct 6, 2023 | 0 |
| Pasternak Andy | EVP, Chief Strategy Officer | 0 | Oct 6, 2023 | 0 |
| Thompson Elizabeth H.Z. | EVP, Research & Development | 0 | Oct 6, 2023 | 0 |
| Clayton Sean M. | EVP, General Counsel | 0Indirect | Oct 6, 2023 | 0 |
| Cox Aaron | EVP, Chief Financial Officer | 0 | Oct 6, 2023 | 0 |
| McIlvenny Patrick | Chief Accounting Officer | 0 | Oct 6, 2023 | 0 |
| Leonardi Jacopo | Pres., Global Commercial Ops | – | Jun 3, 2022 | 0 |
| Hoelscher Paul W. | EVP, CFO | 1,049 | Apr 22, 2022 | 0 |
| McHugh Miles W | Sr VP & Princ. Acctg Officer | 46,635 | Jan 6, 2022 | 0 |
| Moze Barry | EVP, Chief Admin. Officer | 138,174 | Jan 6, 2022 | 0 |
| Beeler Brian K | EVP, General Counsel | 62,775 | Sep 17, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 6, 2021 (view filing) | Aug 5 | 1 day | Thompson Elizabeth H.Z.EVP, Research & Development | SSale | −7.54K | $106.34 | −$802.0K | −34.7%14.2K after | |
| Jul 30, 2021 (view filing) | Jul 30 | Same day | Walbert Timothy PChairman, President and CEO | SSale | −25.0K | $101.74 | −$2.54M | −2.9%840.3K after | 2 lots |
| Jul 23, 2021 (view filing) | Jul 22 | 1 day | Grey Michael GDirector | SSale | −5.00K | $100.04 | −$500.2K | −100.0%0 after | 2 lots |
| Jul 9, 2021 (view filing) | Jul 8 | 1 day | Moze BarryEVP, Chief Admin. Officer | SSale | −35.1K | $92.54 | −$3.25M | −32.9%71.6K after | 3 lots |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −5.29K | $95.00 | −$502.3K | −36.7%9.12K after | |
| Jul 2, 2021 (view filing) | Jul 1 | 1 day | Sherman Jeffrey WEVP and Chief Medical Officer | SSale | −54.8K | $95.00 | −$5.20M | −29.8%128.8K after | |
| Jul 2, 2021 (view filing) | Jun 30 | 2 days | Walbert Timothy PChairman, President and CEO | SSale | −25.0K | $93.86 | −$2.35M | −2.9%850.9K after | 2 lots |